Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:1602-1609
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C.-H.
Right arrow Articles by Kass, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C.-H.
Right arrow Articles by Kass, D. A.

CLINICAL STUDIES

Verapamil acutely reduces ventricular-vascular stiffening and improves aerobic exercise performance in elderly individuals

Chen-Huan Chen, MDa,1, Masaru Nakayama, MD, PhDa, Maurice Talbot, RNa, Erez Nevo, MD, DSca, Barry Fetics, BEa, Gary Gerstenblith, MDa, Lewis C. Becker, MDa and David A. Kass, MDa

a Division of Cardiology, Department of Medicine and Department of Biomedical Engineering, Johns Hopkins University Medical Institutions, Baltimore, Maryland, 21287, USA

Manuscript received June 26, 1998; revised manuscript received December 1, 1998, accepted January 20, 1999.

Reprint requests and correspondence: Dr. David A. Kass, Halsted 500, Division of Cardiology, The Johns Hopkins Hospital, 600 N Wolfe Street, Baltimore, Maryland 21287
dkass{at}eureka.wbme.jhu.edu

OBJECTIVES

We tested the hypothesis that acute intravenous verapamil acutely enhances aerobic exercise performance in healthy older individuals in association with a combined reduction of ventricular systolic and arterial vascular stiffnesses.

BACKGROUND

Age-related vascular stiffening coupled with systolic ventricular stiffening may limit cardiovascular reserve and, thus, exercise performance in aged individuals.

METHODS

Nineteen healthy volunteers with mean age 70 ± 10 years underwent maximal-effort upright ergometry tests on two separate days after receiving either 0.15 mg/kg i.v. verapamil or 0.5 N saline in a double-blind, randomized, crossover study.

RESULTS

Baseline vascular stiffness, indexed by arterial pulse-wave velocity (Doppler) and augmentation index (carotid tonometry) declined with verapamil (–5.9 ± 2.1% and –31.7 ± 12.8%, respectively, both p < 0.05). Preload-adjusted maximal ventricular power, a surrogate for ventricular end-systolic stiffness, also declined by –9.5 ± 3.6%. Peripheral resistance and peak filling rate were unchanged. With verapamil, exercise duration prior to the anaerobic threshold (AT) increased by nearly 50% (260 ± 129 to 387 ± 176 s) with a corresponding 13.4 ± 4.7% rise in oxygen consumption (O2) at that time (both p < 0.01). Total exercise duration prolonged by +6 ± 2.7% (p < 0.05) with no change in maximal O2. Baseline cardiodepression from verapamil reversed by peak exercise with net increases in stroke volume and cardiac output (p < 0.05).

CONCLUSIONS

Acute intravenous verapamil reduces ventriculovascular stiffening and improves aerobic exercise performance in healthy aged individuals. This highlights a role for heart-arterial coupling in modulating exertional capacity in the elderly, suggesting a potentially therapeutic target for aged individuals with exertional limitations.

Abbreviations and Acronyms
  AI = augmentation index
  AT = anaerobic threshold
  Ea = effective arterial elastance
  EDV = end-diastolic volume
  Ees = end-systolic elastance
  EF = ejection fraction
  ESV = end-systolic volume
  Pes = end-systolic pressure
  PFREDV = peak filling rate/EDV
  Psys = arterial systolic pressure
  PWRmax = maximal power
  PWV = pulse wave velocity
  SV = stroke volume
  O = maximal oxygen consumption




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
P. D. Chantler, E. G. Lakatta, and S. S. Najjar
Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise
J Appl Physiol, October 1, 2008; 105(4): 1342 - 1351.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Senzaki, Y. Iwamoto, H. Ishido, S. Masutani, M. Taketazu, T. Kobayashi, T. Katogi, and S. Kyo
Ventricular-Vascular Stiffening in Patients With Repaired Coarctation of Aorta: Integrated Pathophysiology of Hypertension
Circulation, September 30, 2008; 118(14_suppl_1): S191 - S198.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
H. Tanaka and D. R. Seals
Endurance exercise performance in Masters athletes: age-associated changes and underlying physiological mechanisms
J. Physiol., January 1, 2008; 586(1): 55 - 63.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. A. Borlaug, V. Melenovsky, S. D. Russell, K. Kessler, K. Pacak, L. C. Becker, and D. A. Kass
Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction
Circulation, November 14, 2006; 114(20): 2138 - 2147.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
T Weber, J Auer, M F O'Rourke, C Punzengruber, E Kvas, and B Eber
Prolonged mechanical systole and increased arterial wave reflections in diastolic dysfunction
Heart, November 1, 2006; 92(11): 1616 - 1622.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
D. A. Kass
Ventricular Arterial Stiffening: Integrating the Pathophysiology
Hypertension, July 1, 2005; 46(1): 185 - 193.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. S. Najjar, S. P. Schulman, G. Gerstenblith, J. L. Fleg, D. A. Kass, F. O'Connor, L. C. Becker, and E. G. Lakatta
Age and gender affect ventricular-vascular coupling during aerobic exercise
J. Am. Coll. Cardiol., August 4, 2004; 44(3): 611 - 617.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
C. Vlachopoulos, K. Hirata, and M. F O'Rourke
Effect of sildenafil on arterial stiffness and wave reflection
Vascular Medicine, November 1, 2003; 8(4): 243 - 248.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Chemla, I. Antony, Y. Lecarpentier, and A. Nitenberg
Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H614 - H620.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Bonapace, A. Rossi, M. Cicoira, L. Franceschini, G. Golia, L. Zanolla, P. Marino, and P. Zardini
Aortic Distensibility Independently Affects Exercise Tolerance in Patients With Dilated Cardiomyopathy
Circulation, April 1, 2003; 107(12): 1603 - 1608.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. R. Peterson, M. R. Rinder, K. B. Schechtman, R. J. Spina, K. L. Glover, D. T. Villareal, and A. A. Ehsani
Peak exercise stroke volume: associations with cardiac structure and diastolic function
J Appl Physiol, March 1, 2003; 94(3): 1108 - 1114.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Kawaguchi, I. Hay, B. Fetics, and D. A. Kass
Combined Ventricular Systolic and Arterial Stiffening in Patients With Heart Failure and Preserved Ejection Fraction: Implications for Systolic and Diastolic Reserve Limitations
Circulation, February 11, 2003; 107(5): 714 - 720.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. G. Lakatta and D. Levy
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part II: The Aging Heart in Health: Links to Heart Disease
Circulation, January 21, 2003; 107(2): 346 - 354.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. G. Hundley, D. W. Kitzman, T. M. Morgan, C. A. Hamilton, S. N. Darty, K. P. Stewart, D. M. Herrington, K. M. Link, and W. C. Little
Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 796 - 802.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. F. O'Rourke
Diastolic heart failure, diastolic left ventricular dysfunction and exercise intolerance
J. Am. Coll. Cardiol., September 1, 2001; 38(3): 803 - 805.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. J. Zieman, G. Gerstenblith, E. G. Lakatta, G. O. Rosas, K. Vandegaer, K. M. Ricker, and J. M. Hare
Upregulation of the Nitric Oxide-cGMP Pathway in Aged Myocardium : Physiological Response to l-Arginine
Circ. Res., January 19, 2001; 88(1): 97 - 102.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Bertella, P. Valentini, and R. Valentini
Heart rate-lowering drugs such as verapamil improve aerobic exercise performance in healthy elderly individuals: a new way to look at left ventricular diastolic function in the elderly
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1697 - 1697.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Nussbacher, G. Gerstenblith, F. C. O'connor, L. C. Becker, D. A. Kass, S. P. Schulman, J. L. Fleg, and E. G. Lakatta
Hemodynamic effects of unloading the old heart
Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1863 - H1871.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement